Lin X Y, Li C, Zhang T, Chen J, Jiang J J, Zheng Q
Department of Hepatology, Hepatology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fujian Clinical Research Center for Hepatology and Intestinal Diseases, Fuzhou 350005, China.
Zhonghua Gan Zang Bing Za Zhi. 2023 Jan 20;31(1):70-76. doi: 10.3760/cma.j.cn501113-20220118-00031.
To investigate the changes of intestinal wall barrier function and its correlation with infection occurrence in patients with cirrhotic portal hypertension. 263 patients with cirrhotic portal hypertension were split into: the clinically evident portal hypertension (CEPH) combined with infection group ( = 74); CEPH group ( = 104); and Non-CEPH group ( = 85). Among them, 20 CEPH patients and 12 non-CEPH patients in non-infection status were subjected to sigmoidoscopy. Immunohistochemical staining was used to detect the expression of trigger receptor-1 (TREM-1), CD68, CD14, the inducible nitric oxide synthase molecule, and Escherichia coli () in the medullary cells of the colon mucosa. An enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of soluble myeloid cell trigger receptor-1 (sTREM-1), soluble leukocyte differentiation antigen-14 subtype (sCD14-ST) and intestinal wall permeability index enteric fatty acid binding protein (I-FABP). Fisher's exact probability method, one-way ANOVA, Kruskal-Wallis-H test, Bonferroni method, and Spearman correlation analysis were used for statistical analysis. The serum sTREM-1 and I-FABP levels were higher in CEPH patients than those of non-CEPH patients in the non-infectious state ( < 0.05), but the difference in blood sCD14-ST levels was not statistically significant ( > 0.05). Serum levels of sTREM-1, sCD14-ST, and I-FABP in infected patients were higher than those in patients without a concurrent infection ( < 0.05). Serum sCD14-ST levels were positively correlated with serum sTREM-1, C-reactive protein (CRP), and procalcitonin (PCT), and sTREM-1 levels were also positively correlated with CRP and PCT ( > 0.5, < 0.001). The rates of CD68, inducible nitric oxide synthase, CD14-positive cells, and -positive glands were higher in the intestinal mucosa of the CEPH group than those of the control group ( < 0.05). Spearman's correlation analysis showed that the rate of -positive glands in CEPH patients was positively correlated with the expression of molecular markers CD68 and CD14 in the lamina propria macrophages. Patients with cirrhotic portal hypertension have increased intestinal permeability and inflammatory cells, accompanied by bacterial translocation. Serum sCD14-ST and sTREM-1 can be used as indicators to predict and evaluate the occurrence of infection in patients with cirrhotic portal hypertension.
探讨肝硬化门静脉高压症患者肠壁屏障功能变化及其与感染发生的相关性。将263例肝硬化门静脉高压症患者分为:临床显性门静脉高压(CEPH)合并感染组(n = 74);CEPH组(n = 104);非CEPH组(n = 85)。其中,选取20例非感染状态的CEPH患者和12例非CEPH患者进行乙状结肠镜检查。采用免疫组织化学染色法检测结肠黏膜髓样细胞中触发受体-1(TREM-1)、CD68、CD14、诱导型一氧化氮合酶分子及大肠杆菌(E. coli)的表达。采用酶联免疫吸附测定(ELISA)法检测可溶性髓样细胞触发受体-1(sTREM-1)、可溶性白细胞分化抗原14亚型(sCD14-ST)及肠壁通透性指标肠型脂肪酸结合蛋白(I-FABP)水平。采用Fisher确切概率法、单因素方差分析、Kruskal-Wallis-H检验、Bonferroni法及Spearman相关分析进行统计学分析。非感染状态下,CEPH患者血清sTREM-1和I-FABP水平高于非CEPH患者(P < 0.05),但血sCD14-ST水平差异无统计学意义(P > 0.05)。感染患者血清sTREM-1、sCD14-ST和I-FABP水平高于未合并感染患者(P < 0.05)。血清sCD14-ST水平与血清sTREM-1、C反应蛋白(CRP)及降钙素原(PCT)呈正相关,sTREM-1水平也与CRP和PCT呈正相关(r > 0.5,P < 0.001)。CEPH组肠黏膜中CD68、诱导型一氧化氮合酶、CD14阳性细胞及E. coli阳性腺体的比例高于对照组(P < 0.05)。Spearman相关分析显示,CEPH患者E. coli阳性腺体比例与固有层巨噬细胞中分子标志物CD68和CD14的表达呈正相关。肝硬化门静脉高压症患者肠通透性和炎性细胞增加,伴有细菌移位。血清sCD14-ST和sTREM-1可作为预测和评估肝硬化门静脉高压症患者感染发生的指标。